Format

Send to

Choose Destination
Clin Nucl Med. 2019 Nov;44(11):923-924. doi: 10.1097/RLU.0000000000002790.

Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT.

Author information

1
From the Department of Nuclear Medicine, University Hospital, LMU Munich, Munich.
2
German Cancer Consortium (DKTK), partner site Munich.
3
Department of Neuropathology and Prion Research.
4
Department of Radiology, University Hospital.
5
Department of Neurosurgery, University Hospital, LMU Munich, Munich.
6
Institute of Neuropathology.
7
Department of Pediatric Hematology and Oncology, University Medical Center, Hamburg-Eppendorf.
8
Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.

Abstract

A 51-year-old man presented with recurrent gliosarcoma and increasing cough over the last months. On F-FDG PET/CT, solid lung masses with high F-FDG uptake were present. A biopsy taken from a lung lesion indicated distant metastases from gliosarcoma. Gliosarcoma, a rare malignant central nervous system tumor, presents with extracranial metastases in only less than 10%. As highlighted by this case, F-FDG PET/CT can be used for whole-body staging in patients with metastatic brain tumor. Vice versa, highly F-FDG-avid lung lesions in patients with brain tumors should lead to distant metastases as differential diagnosis despite their rare occurrence.

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center